Ligand · VDA
VDA · (1R,2R,3R,5Z)-17-{(1S)-1-[(2-ethyl-2-hydroxybutyl)sulfanyl]ethyl}-2-(2-hydroxyethoxy)-9,10-secoestra-5,7,16-triene-1,3-diol
VDA, (1R,2R,3R,5Z)-17-{(1S)-1-[(2-ethyl-2-hydroxybutyl)sulfanyl]ethyl}-2-(2-hydroxyethoxy)-9,10-secoestra-5,7,16-triene-1,3-diol (C28 H46 O5 S, 494.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- VDA
- Formula
- C28 H46 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VDA in 2 structures; the first of them:
- 2ZL9 · 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs… · VDA A500 · binds THR142, TYR143, ASP144, TYR147, PHE150, LEU223, LEU226, ALA227 and 22 more
- 2ZL9 · 2-substituted-16-ene-22-thia-1ALPHA,25-dihydroxy-26,27- dimethyl-19-norvitamin D3… · VDA A500 · binds THR142, TYR143, ASP144, TYR147, PHE150, LEU223, LEU226, ALA227 and 22 more
Residues it binds most
TYR 2, LEU 2, SER 2, VAL 2, ALA 2, HIS 2, ILE 2, PHE 2, ARG 2, ASP 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.